# B3GALT5

## Overview
The B3GALT5 gene encodes the enzyme beta-1,3-galactosyltransferase 5, a glycosyltransferase that plays a pivotal role in the biosynthesis of type 1 chain carbohydrates in mammals. This enzyme is integral to the formation of specific glycans, including histo-blood group antigens and human embryonic stem cell markers, which are essential for various biological processes such as cell-cell communication and immune response (Cai2020SSEA3; Zulueta2013Transcriptional). Predominantly active in the Golgi apparatus, beta-1,3-galactosyltransferase 5 catalyzes the transfer of galactose to N-acetylglucosamine, contributing to the synthesis of complex glycosphingolipids (Isshiki1999Cloning). The expression and regulation of B3GALT5 are crucial for maintaining cellular functions and have significant implications in metabolic disorders and cancer, where its altered expression can affect disease progression and cellular behavior (Trinchera2014Control; Zhang2024B3galt5).

## Function
The B3GALT5 gene encodes the enzyme beta-1,3-galactosyltransferase 5, which plays a critical role in the biosynthesis of type 1 chain carbohydrates in mammals. This enzyme is involved in the synthesis of specific glycans, including the histo-blood group antigens Lewis a, Lewis b, and sialyl-Lewis a, as well as the human embryonic stem cell markers SSEA3 and SSEA4 (Cai2020SSEA3; Zulueta2013Transcriptional). In healthy human cells, B3GALT5 is primarily active in the Golgi apparatus, where it catalyzes the transfer of galactose to N-acetylglucosamine, forming lactosylceramide, a precursor for complex glycosphingolipids (Isshiki1999Cloning).

The enzyme's activity is crucial for cell-cell communication, adhesion, and signal transduction, impacting processes such as cell signaling and immune response (Trinchera2014Control). B3GALT5 expression is notably high in the colon and is involved in the synthesis of glycans that play roles in cell signaling and are associated with cancer cell survival, migration, and invasion (Cai2020SSEA3). The regulation of B3GALT5 involves complex interactions between transcription factors, chromatin remodeling, and DNA methylation, which are essential for its tissue-specific expression and function (Trinchera2014Control).

## Clinical Significance
Alterations in the expression of the B3GALT5 gene have been implicated in several metabolic and cancer-related conditions. In the context of obesity and insulin resistance, B3GALT5 plays a crucial role in maintaining intestinal integrity. Its deficiency leads to increased intestinal permeability, disrupted mucus O-glycosylation, and elevated serum endotoxin levels, which contribute to obesity and insulin resistance (Zhang2024B3galt5). B3GALT5 deficiency is associated with increased body weight, larger adipocytes, impaired glucose tolerance, and insulin sensitivity, as well as increased inflammation and macrophage infiltration in adipose tissue (Zhang2024B3galt5).

In cancer, B3GALT5 is involved in the synthesis of type 1 chain structures, including tumor markers such as sialyl Lewis a (sLe a), which are important in colorectal and pancreatic cancers. The expression of B3GALT5 correlates with the presence of these antigens, which are associated with cancer cell migration, invasion, and metastasis (Isshiki1999Cloning). The gene's expression is regulated by DNA methylation, which can be aberrant in cancer, leading to altered glycosylation patterns that may influence cancer progression (Trinchera2014Control). These findings highlight the clinical significance of B3GALT5 in both metabolic disorders and cancer.


## References


[1. (Cai2020SSEA3) Bi-He Cai, Hsueh-Yi Lee, Chi-Kan Chou, Po-Han Wu, Hsiang-Chi Huang, Chia-Chun Chao, Hsiao-Yu Chung, and Reiji Kannagi. Ssea3 and sialyl lewis a glycan expression is controlled by b3galt5 ltr through lamin a-nfya and sirt1-stat3 signaling in human es cells. Cells, 9(1):177, January 2020. URL: http://dx.doi.org/10.3390/cells9010177, doi:10.3390/cells9010177. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cells9010177)

[2. (Zulueta2013Transcriptional) Aida Zulueta, Anna Caretti, Paola Signorelli, Fabio Dall’Olio, and Marco Trinchera. Transcriptional control of theb3galt5gene by a retroviral promoter and methylation of distant regulatory elements. The FASEB Journal, 28(2):946–955, October 2013. URL: http://dx.doi.org/10.1096/fj.13-236273, doi:10.1096/fj.13-236273. This article has 15 citations.](https://doi.org/10.1096/fj.13-236273)

[3. (Trinchera2014Control) Marco Trinchera, Aida Zulueta, Anna Caretti, and Fabio Dall’Olio. Control of glycosylation-related genes by dna methylation: the intriguing case of the b3galt5 gene and its distinct promoters. Biology, 3(3):484–497, August 2014. URL: http://dx.doi.org/10.3390/biology3030484, doi:10.3390/biology3030484. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/biology3030484)

[4. (Zhang2024B3galt5) Jinhang Zhang, Ya Huang, Hong Li, Pengfei Xu, Qinhui Liu, Yang Sun, Zijing Zhang, Tong Wu, Qin Tang, Qingyi Jia, Yan Xia, Ying Xu, Xiandan Jing, Jiahui Li, Li Mo, Wen Xie, Aijuan Qu, Jinhan He, and Yanping Li. B3galt5 functions as a pxr target gene and regulates obesity and insulin resistance by maintaining intestinal integrity. Nature Communications, July 2024. URL: http://dx.doi.org/10.1038/s41467-024-50198-z, doi:10.1038/s41467-024-50198-z. This article has 0 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-024-50198-z)

[5. (Isshiki1999Cloning) Soichiro Isshiki, Akira Togayachi, Takashi Kudo, Shoko Nishihara, Masahiko Watanabe, Tetsuro Kubota, Masaki Kitajima, Norihiko Shiraishi, Katsutoshi Sasaki, Toshiwo Andoh, and Hisashi Narimatsu. Cloning, expression, and characterization of a novel udp-galactose:β-n-acetylglucosamine β1,3-galactosyltransferase (β3gal-t5) responsible for synthesis of type 1 chain in colorectal and pancreatic epithelia and tumor cells derived therefrom. Journal of Biological Chemistry, 274(18):12499–12507, April 1999. URL: http://dx.doi.org/10.1074/jbc.274.18.12499, doi:10.1074/jbc.274.18.12499. This article has 110 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.274.18.12499)